Päivi Taavitsainen

SELECTIVE INHIBITION OF CYP2B6-CATALYZED BUPROPION HYDROXYLATION IN HUMAN LIVER MICROSOMES IN VITRO

Miia Turpeinen, Riina Nieminen, Tarja Juntunen et al. · Drug Metabolism and Disposition · 2004 · 107 citations

Involvement of CYP1A2 and CYP3A4 in Lidocaine N-Deethylation and 3-Hydroxylation in Humans

Junsheng Wang, Janne T. Backman, Päivi Taavitsainen et al. · Drug Metabolism and Disposition · 2000 · 106 citations

In vitro inhibition of cytochrome P450 enzymes in human liver microsomes by a potent CYP2A6 inhibitor, trans-2-phenylcyclopropylamine (tranylcypromine), and its nonamine analog, cyclopropylbenzene.

Päivi Taavitsainen, Risto O. Juvonen, Olavi Pelkonen · PubMed · 2001 · 78 citations

Nonamine Analog, Pharmacotherapy, Experimental Pharmacology +18

Midazolam α‐Hydroxylation by Human Liver Microsomes<i>in vitro</i>: Inhibition by Calcium Channel Blockers, Itraconazole and Ketoconazole

Jun‐Sheng Wang, Wen Xia, Janne T. Backman et al. · Pharmacology & Toxicology · 1999 · 68 citations · Full text

COMPARATIVE STUDIES ON THE CYTOCHROME P450-ASSOCIATED METABOLISM AND INTERACTION POTENTIAL OF SELEGILINE BETWEEN HUMAN LIVER-DERIVED IN VITRO SYSTEMS

Jarmo S. Salonen, Leena Nyman, Alan R. Boobis et al. · Drug Metabolism and Disposition · 2003 · 66 citations